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SUMMARY Until recently, obstructive sleep apnoea
was a largely unknown condition. Because of the
well-publicised death of some high-profile people
resulting from untreated obstructive sleep apnoea,
now mostly everyone has heard of the condition.
Following diagnosis, several medical treatment
modalities are available to patients. However, the
role that dentistry and its various specialties can
play in successful treatment for obstructive sleep
apnoea should not be overlooked. The common
causes for adult and paediatric obstructive sleep
apnoea will be presented as well as a review of the
more successful forms of dental treatment. Finally,
a summary of the current evidence regarding
obstructive sleep apnoea treatment will be pre-
sented.
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Introduction
Chronic obstructive sleep apnoea (OSA) is a severe
debilitating disorder. People of all ages are affected, but
overweight middle age adult males have the highest
prevalence of the disease (1). Women are affected by
OSA, but to a lesser degree (2). Recently, OSA is being
seen in greater numbers even within the paediatric and
adolescent age range (3). Several disciplines of dentistry
are well equipped to provide treatment for patients
with OSA owing to their education in facial growth and
development as well as craniofacial and dentofacial
anomalies. Some patients may not routinely see their
medical doctor and may be unaware of the condition
(4). Observant dentists who typically see patients more
frequently than their medical colleagues may pick up
signs and symptoms of OSA during the dental visit.
When seen, the dental practitioner must make a
referral to the sleep team for diagnosis. With the
diagnosis complete, several treatment modalities are
available (5–9). Successful treatment improves the
patient’s subjective and objective assessment of their
daytime alertness (10–13). Forms of treatment that the
dental professional already performs can be highly
successful for the affected patient and provide a signif-
icant service and health benefit beyond improving the
patients smile and self-esteem.
Part 1: the adult OSA patient
Diagnosis and classification of adult
obstructive sleep apnoea
The classic symptom of OSA is excessive daytime
sleepiness. The Epworth Sleepiness Exam is an easy,
inexpensive screening tool that asks patients a series of
questions (14). At the conclusion of the form, the
relative sleep health and sleepiness of the patient is
determined. However, this test is extremely limited; it is
not able to differentiate OSA from the many other types
of sleep-disordered breathing such as restless leg syn-
drome and other conditions.
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The gold standard for proper diagnosis of obstructive
sleep apnoea is an overnight polysomnography which
can be performed at either a full service hospital or an
independent free standing accredited sleep clinic (15).
Polysomnography exams combine the results of elec-
troencephalogram (EEG), electrocardiogram (EKG),
electrooculogram (EOG), electromyography (EMG)
along with respiration rate, tidal volume, inspiration
and expiration volumes the severity of OSA. The
primary indicator of severity is the AHI or the apnoea
hypopnea index. An apnoea is defined as a cessation in
breathing for 2 s or more with an arterial oxygen
desaturation of two to four per cent (16). A hypopnea is
a fifty per cent decrease in airflow for 10 s or more with
a concomitant drop in arterial oxygen saturation (16).
Normal sleep is defined as an AHI of five or less. Mild
sleep apnoea has an AHI of 5-15. Patients with
moderate sleep apnoea have an AHI between 15 and
30 events per hour, while patients with severe apnoea
have an AHI over 30 (16). To more critically assess sleep
apnoea severity, the AHI is subdivided into an apnoea
index (AI) and a hypopnea index (HI). A patient with
primarily apnoeas is more severe than another patient
who has the same AHI but predominantly hypopnoeas.
These differences are important and may lead to
significantly different treatment approaches. To put
the AHI into context, a patient with an AHI of 60 stops
breathing or has a significant oxygen desaturation for at
least 10 s every minute. This events lead to significant
reduction in oxygen perfusion to the brain causing an
increased risk of stroke, myocardial infarction and other
cardiac anomalies (17).
Differentiation of central apnoea from obstructive
apnoea is essential (18). With obstructive apnoea,
respiratory effort (documented by EMG) is present yet
the patient is unable to adequately ventilate. In central
apnoea patients have diminished or no respiratory
effort. While certain forms of treatment are effective for
both, treatment provided by the dental professional is
only effective for obstructive apnoea. Providing
obstructive sleep apnoea therapy for a central sleep
apnoea patient can result in inadequate and inappro-
priate treatment.
The guidelines for successful treatment vary widely,
but the primary goal is to decrease the morbidity and
mortality associated with the sleep disordered breathing.
The most stringent criteria for success are achieving an
AHI of <10. More conservative success criteria attempt to
achieve at least a 50% reduction in the AHI or an AHI of
<20. A recent report states successfully treated patients
have no increased morbidity or mortality (19). For
untreated individuals, there is a 37% higher 5 -year
morbidity and mortality (12). The morbidity and mor-
tality statistics result from higher incidence of motor
vehicle accidents, heart attack, stroke, arrhythmia and
hypertension. One study concluded that the incidence of
motor vehicle accidents with obstructive sleep apnoea
are comparable to driving while intoxicated, which
presents a major public health risk (20, 21).
Imaging modalities: lateral cephalometrics, MRI and CBCT
evaluation
Dental practitioners trained in cephalometrics (com-
monly orthodontists, paediatric dentists and oral and
maxillofacial surgeons), use these radiographs to ana-
lyse traditional skeletal and dental relationships as well
as incorporate an airway analysis. Each assessment
compares the patient’s measures to a set of ‘normative’
values. Unfortunately, lateral cephalometric analysis
only provides information on two dimensions; the
vertical and sagittal. The third dimension (transverse) is
left entirely unanalysed unless the practitioner utilises a
posterior anterior cephalometric radiograph (PA film).
A sample lateral cephalometric tracing that includes the
common lateral cephalometric landmarks is shown in
Fig. 1. Table 1 lists each lateral cephalometric landmark
with its anatomical definition. Each cephalometric
analysis is generally broken down into categories
such as:
1 Cranial base measures
2 Horizontal maxillary and mandibular skeletal
measures
3 Vertical maxillary and mandibular skeletal and den-
tal measures
4 Intramaxillary and intramandibular measures
5 Dental measures
6 Airway measures
When individual patient measures are compared to
‘ideal’ standards, (the cephalometrics for orthognathic
surgery analysis (COGS) was used here) (22), the
patient is assigned the appropriate skeletal diagnosis.
Class I, (normal), skeletal relationship patients have
well-balanced faces with good position and projection
of the maxilla and mandible. Patients with Class II
relationships are typically more convex either from
maxillary overgrowth (maxillary hyperplasia), a man-
dibular undergrowth (mandibular hypoplasia) or a
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combination of the two. The Class III skeletal patient
demonstrates the exact opposite problem; maxillary
hypoplasia, mandibular hyperplasia, or a combination
of the two. Fig. 2a–c) demonstrates the lateral cepha-
lometric tracings representative of the three different
skeletal classifications.
Mild skeletal deviations from ideal generally do not
constitute an increased risk of OSA. However, signifi-
cant jaw abnormalities, particularly mandibular micro-
gnathia, have been linked to OSA especially within the
paediatric population (23). By examining the following
cephalometric tracing (See Fig. 3), one can readily
observe how this patient’s mandibular deficiency
results in a functional airway deficit. This can be
further impaired in craniofacial malformations such as
Pierre-Robin sequence, Goldenhaar Syndrome or Mar-
fan Syndrome (24).
While cephalometric analysis alone is insufficient to
diagnose OSA, some cephalometric indicators have
been reported to indicate the potential for OSA and
the need for additional testing. One cephalometric
measure is the linear distance from the mandibular
plane to the hyoid bone (MP–H). A distance >15Æ4 mm
Fig. 1. A representative lateral cephalometric tracing. The indi-
vidual landmarks are marked with dots. For a complete anatom-
ical description of the landmarks, see Table 1.
Table 1. Cephalometrics for orthognathic surgery landmarks
Skeletal (Bony) landmarks
S: Sella; the geometric centre of the sella turcica
N: Nasion; the intersection of the nasal bones and the frontal bone
in the midsagittal plane
ANS: Anterior nasal spine; the most anterior point of the bony
maxilla
PNS: Posterior nasal spine; the most posterior point of the bony
maxilla
A: ‘A’ point; the deepest point on the anterior surface of the bony
maxilla between ANS and the upper incisor
U1: Upper incisor; the most inferior point on the upper central
incisor
U6: Upper first molar; the most mesial portion of the upper first
molar
L1: Lower incisor; the most superior point of the lower central
incisor
L6: Lower first molar; the most mesial portion of the lower first
molar
B: ‘B’ point; the deepest portion on the anterior contour of the
mandible between the lower incisor and pogonion
Pg: Pogonion; the most prominent point on the anterior surface of
the mandible
Gn: Gnathion; a constructed point midway between pogonion and
menton
Me: Mention; the most inferior point on the bony chin
Go: Gonion; the most posterior-inferior point on the gonial angle
of the mandible
Ar: Articulare; the radiographic superimposition of the ascending
ramus and the cranial base
Cd: Condylion; the most posterior superior point on the mandib-
ular condyle
Cor: Coronoid process; the most superior point on the coronoid
process
Pt: Most posterior superior point of the pterygomaxillary fissure
Po: Porion; the midpoint of the superior aspect of the external
auditory meatus
Soft tissue landmarks
G: Glabella; the most anterior point of the forehead above the nose
N’: Soft tissue nasion
Cm: Columella
Sn: Subnasale; the junction of the inferior aspect of the nose and
superior component of the upper lip
Ss: Superior sulcus; the deepest point on the curvature of the
upper lip
Ls: Labrale superius; the most prominent point of the upper lip
Stm: Stomion; the intersection of the upper and lower lips. (When
the lips do not contact, stomion is the midpoint between the upper
and lower lip)
Li: Labrale inferius; the most prominent point of the lower lip
Si: Sulcus inferius; the deepest point on the curvature of the lower
lip. Also known as soft tissue ‘B’ point or the mentolabial fold
Pg’: Soft tissue pogonion; the most prominent point on the
anterior contour of the soft tissue chin
Gn’: Soft tissue gnathion; a constructed point midway between
soft tissue pogonion and soft tissue menton
Me’: Soft tissuementon; themost inferiorpointof thesoft tissuechin
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indicates a person at risk for OSA (25, 26). Elevated
values indicate a collection of soft tissue, frequently
adipose tissue, present in the submental and para-
pharyngeal region. This collection of tissue creates
pressure, facilitating airway collapse. A collection of
skeletal cephalometric measures including an increased
mandibular plane angle, steep occlusal plane, over-
erupted posterior dentition, large gonial angle and
anterior open bite reportedly represent an increased
risk for OSA (27).
Some soft tissue measures, especially those associated
with soft palate dimensions, can also indicate a need for
polysomnography. A longer soft palate (25, 26) and a
wider soft palate can combine to reduce the posterior
air space (PAS) (28–30). The combination of these
factors is represented in a figure by Cistulli (30) where
he presents side-by-side figures demonstrating a patient
with a normal airway and a second patient with a
reduced airway (See Fig. 4).
Because of its ability to accurately visualise soft
tissues, several MRI studies of the airway have been
conducted. Conflicting evidence is present; one study
found that the volumes of the lateral pharyngeal
walls, tongue and total soft tissue were larger in
patients with OSA (31), while a second study found
that the tongue, soft palate and lateral pharyngeal wall
volume was not significantly different (32). Such lack
of agreement indicates that better research with larger
(a) (b) (c)
Fig. 2. Lateral cephalometric views of three distinct skeletal malocclusion. (a) depicts a patient with nearly ideal skeletal and dental
balance. (b) depicts a patient with a Class II skeletal malocclusion. Note the significant mandibular deficiency, the everted lower lip, and
the significant horizontal distance between the upper and lower incisors. (c) depicts the opposite, a skeletal Class III patient with
mandibular hyperplasia and maxillary hypoplasia. Note the reverse overlap of the incisors, the upper incisor is behind the lower incisor.
Fig. 3. In this mandibular deficient patient, the airway is also
drawn. Note the significant narrowing of the airway extending
from the tip of the soft palate inferiorly towards the epiglottis. This
airway can become narrower in the supine position during sleep.
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sample sizes, more stringent inclusion and exclusion
criteria and standardised evaluation parameters is
needed.
Cone-beam computed tomography (CBCT) is a re-
cently developed low-dose three-dimensional imaging
technique that can generate a scan of the entire head
(33). Recent publications have demonstrated that
(CBCT) produces extremely accurate anatomical repre-
sentations (34–36). These imaging modalities also dem-
onstrate diminished airway prior to treatment and the
significant changes that occur following successful treat-
ment (37, 38). However, like the MRI studies described
earlier, conflicting results have been reported. One study
(39) (36 subjects but only 10 controls) concluded that the
minimum cross-sectional airway in patients with OSA
was smaller than controls. A different study (40) with 40
patients with OSA of mixed gender and 10 controls also of
mixed gender found no differences.
Adult treatment modalities
The American Sleep Disorders Association (ASDA)
which has been renamed the American Association of
Sleep Medicine (AASM) describes eight surgical treat-
ment options and five conservative treatment options
for the patient with OSA (Table 2). Following PSG
examination and diagnosis, dental professionals trained
in the area of sleep medicine can perform the four of
the five conservative treatment interventions listed
with oral appliance therapy being the most popular and
most successful. Of the surgical procedures, genio-
plasty, mandibular advancement, maxillomandibular
advancement (MMA) are most frequently performed
by the oral and maxillofacial surgeon in collaboration
with other dental colleagues. The success of MMA
requires interdisciplinary care between orthodontics,
prosthodontics, general dentistry, and oral and maxil-
lofacial surgery to provide the best orofacial care for the
patient.
Oral appliance therapy
Appliance types. Oral appliances have repeatedly been
shown to be an effective form of treatment for mild to
(b)(a)
Fig. 4. (a) demonstrates a ‘normal’
airway with normal skeletal posi-
tioning of both jaws. (b) shows a
patient with a longer face height,
mildly deficient jaw position and
narrower airway. Reprinted from
Cistulli PA. Craniofacial abnormal-
ities in OSA: implications for treat-
ment. Respirology 1996;3:167.
Table 2. Summary of accepted OSA treatment options. Several










Adenoidectomy (T & A)
Altering sleep
position
Genial advancement (with or
without hyoid myotomy)
Oral appliance





Surgical interventions in bold are procedures that may be
performed by dental specialists such as oral and maxillofacial
surgeons.
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moderate obstructive sleep apnoea and even patients
with severe sleep apnoea (AHI > 30) who cannot
tolerate CPAP or refuse surgical correction. For patients
with severe sleep apnoea, reduction in AHI may be
observed but it may not be brought into the normal
range. While any decrease is beneficial, if the AHI is not
brought below 20 significant long-term health risks are
still present.
In the supine position, all gravity-dependent tissues
including the tongue tend to fall posteriorly. The tongue
base is held anteriorly by the genial tubercles. If this
support is insufficient a tongue retaining device can be
utilised. To fit a tongue appliance, a piece of dental floss
is gently wrapped around the tongue, removed, and
measured. The appliance comes in three different sizes
(small, medium, and large) and two different styles,
(dentate and non-dentate). The appliance bulb is
moistened, compressed and the tongue is inserted. The
negative pressure and the salivary adhesion act syner-
gistically to maintain the tongue in a more forward
position opening the oropharyngeal airway. This class of
appliance is not utilised often as most patients find it
uncomfortable and compliance is poor.
A second class of appliances actively protrudes the
mandible and maintains this forward position during
sleep, (See Fig. 5). Several types of appliances are
available including the Kleerway developed by orth-
odontists, the Tap (and its variations) developed by a
prosthodontist and other variations on this theme. Each
oral appliance is removable and allows patient insertion
at night and removal in the morning. Because the
appliance is small compared to CPAP the oral appliances
are much more portable; they can even be taken on
vacation or other trips away from home. Another
advantage is that oral appliance therapy is relatively
inexpensive and is entirely reversible. If the patient
does not obtain improvement, no permanent changes
have occurred and alternative treatment options can be
explored. Selection of the specific advancing appliance
can be made using multiple factors including cost,
convenience, durability, adjustability, and patient com-
fort. Because all anterior repositioning appliances
function similarly, freedom exists for the patient and
dental professional to individually select the appliance
that will be the most comfortable. This potentially aids
compliance that is essential because like CPAP, if the
oral appliance is not worn, improvement cannot be
obtained.
Oral appliance fabrication and treatment. To fabricate,
upper and lower dental impressions are obtained. The
pre-treatment range of motion including maximum
opening, left and right lateral excursion, and maximum
protrusion are measured. The appliance is constructed
using a position approximately one-half to two-thirds
of the patient’s maximum protrusion and several
millimetres open. Custom bite registrations in centric
occlusion and the advanced position are obtained. A
George gauge can be helpful in stabilizing the patient in
the construction bite position. The impressions and bite
registrations are either sent to a commercial laboratory
for fabrication or made in house. In house appliances
are typically more cost effective for the patient and can
be delivered more quickly.
Prior to appliance delivery, a lateral cephalometric
radiograph is taken in centric occlusion to document
the baseline position. This may also be used later to
assess possible bite changes as well as documenting the
amount of airway opening. At the delivery appoint-
ment, appliance fit and comfort are assessed and
instructions are given to the patient. Follow-up lateral
cephalograph (or CBCT) and polysomnography are
(a) (b)
Fig. 5. Sample of oral appliances. (a) Kleerway appliance. The expansion screw is oriented in a sagittal direction to enable a custom
amount of mandibular protrusion to be established for each patient. (b) A custom made mandibular protrusion appliance. The acrylic
flange can be augmented or reduced to enable greater or lesser amounts of protrusion to be obtained.
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taken after appropriate appliance adjustment ⁄ titration
and patient adaptation periods. Using lateral cephalo-
metric radiographs, Liu et al. (41) demonstrated a
two-dimensional airway change. Haskell et. al. (42)
followed up with CBCT demonstrating the three-
dimensional airway change following oral appliance
therapy. However, to appropriately, accurately, and
objectively determine the effect oral appliance treat-
ment has on obstructive sleep apnoea it is essential to
obtain a follow up sleep study with the appliance in
place. Subjectively, patients will nearly universally
report positive changes; however, these may not be
substantiated in the follow-up polysomnography. If
objective improvement is not observed, the patient
must be counselled on alternate treatment options to
adequately treat their sleep apnoea.
Dental practitioners who provide treatment for OSA
must be aware of and comply with the AASM treat-
ment parameters for oral appliances that were first
established in 1995. At that time, on the best available
evidence were a limited number of case series investi-
gations. As patient care has continued, higher levels of
evidence including prospective randomised clinical
trials have become available resulting in the 2005
AASM revised practice parameters (43). The AASM’s
strongest parameter is a practice standard that is estab-
lished only after well-designed prospective randomised
clinical studies demonstrate that treatment is beneficial
and safe. A practice guideline is developed from lower
levels of evidence such as case series or prospective
studies with high potential bias. Practice parameters list
treatment possibilities with minimal literature support.
The underlying goal of the AASM is to highlight the
current evidence and illustrate future research initia-
tives in order to systematically and continually improve
treatment outcomes (44).
Evidence regarding oral appliances. Several case series and
prospective studies have been performed, but sample
sizes, lack of controls, unclear randomisation methods
and other factors make interpretation and application of
these investigations difficult. Hoekema (45) published a
meta-analysis regarding oral appliance use in 2004.
Using a systematic approach with clearly stated inclu-
sion criteria, only 13 of the possible 289 relevant papers
were included. Only three mandibular repositioning
appliance studies that utilised a prospective randomised
design with control patients were available. Each of the
three papers demonstrated a positive effect from man-
dibular repositioning appliances; however, the effect
size varied (46–48). Pooling the data resulted in a small
positive treatment effect. Hoekema concludes that
further study including investigations regarding the
possible placebo effect must be conducted.
To address these weaknesses, Blanco (49) performed
a prospective randomised controlled study. The study
compared a mandibular advancement appliance with a
control mandibular appliance (similar design but with-
out advancement). One significant study limitation was
its small sample size; (twenty four patients started but
only 15 completed the study). In addition, only a
limited treatment benefit was reported. The AHI in the
treatment group declined from 33 to 9Æ6, while the
control group declined unexpectedly from 24 to 11Æ7. A
larger effect was observed in the subjective Epworth
Sleep Scale where the treatment group improved from
14Æ7 to 5Æ1 compared while the control group failed to
demonstrate a significant change (16Æ3–13Æ6). Based on
this study, it is unclear why the control group experi-
enced positive changes in the AHI; it is possible there
was some unintended bite opening or unanticipated
change in bite position during sleep.
To improve on these limitations, Petri in 2008
improved both the study design and the study popu-
lation (50). Petri et. al. randomly assigned patients to a
mandibular repositioning appliance group, a ‘sham’
appliance group, and a no treatment group. To inves-
tigate for a potential placebo effect, the ‘sham’ appli-
ance group was compared to both the no treatment
group and the treatment group. Ninety-three patients
were initially enrolled; twelve were lost in follow-up
leaving 81 patients available for analysis. The mandib-
ular repositioning appliance demonstrated a clinically
significant improvement in the AHI, the Epworth Sleep
scale and the SF-36 quality of life assessment. To
attempt to determine the patients most likely to
improve, Petri separated the treatment group into
moderate (patients with an AHI between 15 and 30)
and severe (patients with AHI over 30). Nearly half of
both groups experienced a 50% reduction in AHI. Fifty
eight per cent of the moderate group improved to an
AHI <10, while only twenty-six per cent of the severe
group achieved the same goal. One-third of the mod-
erate and one quarter of the severe group were brought
into the normal (AHI < 5) range. However, while the
mean patient (AHI = 39Æ1) significantly improved (AHI
25), they were left in the moderate sleep apnoea
category. A more modest decline in the Epworth Sleep
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Scale (11Æ7 improving to 8Æ4) was observed. Neither the
control group nor the non-advancing appliance group
experienced improvement in AHI demonstrating a lack
of placebo effect. In both the Epworth Sleep Scale and
SF-36 quality of life surveys, patients reported improve-
ment demonstrating some level of subjective results
from these instruments.
Several other studies investigating the effects of oral
appliances have been performed. However, although
prospective in nature, the studies often compare two
treatment appliances that do not include a control
population, have a cross-over design, have short study
duration, and suffer from small sample sizes.
Because CPAP is currently the ‘gold standard’ treat-
ment, the effect of mandibular repositioning appliances
must be compared with CPAP. When systematic com-
parisons are performed, CPAP demonstrates more
favourable results than oral appliances (45). The greater
effect from CPAP is also supported by the 2006 Cochrane
Collaboration report that only included controlled
randomised studies and specifically excluded pre-post-
treatment outcomes and case series publications (con-
secutive or non-consecutive) (51). Within the report, ten
studies compared oral appliances with CPA. The Epworth
scale, AHI, arousals, O2 sat, quality of life indicators and
BP were examined as well as cognitive assessment,
patient preference, and withdrawals from the study. The
summary supports the generally accepted conclusion
that CPAP is superior to oral appliances regarding both
the AHI and the Epworth Sleepiness scale.
With any type of elective treatment, compliance
must be considered. Within the studies selected by the
Cochrane Collaboration, larger numbers of patients
withdrew from the oral appliance group than the CPAP
group. This is in conflict with other surveys, case series,
and anecdotal reports that generally state extremely
low CPAP compliance. It is likely that this difference
results from the study period. The longer the follow-up
period, the fewer patients (as low as 30–40%) continue
to utilise CPAP. While compliance is a factor with both
treatment modalities, patients who experienced a
positive treatment effect appeared to prefer the oral
appliance over CPAP.
Using the best evidence currently available, it is clear
that appropriately performed oral appliance therapy is a
viable treatment alternative for patients with mild to
moderate sleep apnoea and for patients who are unable
or unwilling to comply with CPAP. However, one must
also consider the limitations and potential side effects.
Published reports that include individual patient results
demonstrate that some patients respond to OA and
others do not (52, 53). In addition, dental changes can
occur (54, 55). In one study over a 7 -year period,
14Æ3% of oral appliance patients had no dental changes.
A large number of patients experienced favourable
change (41Æ4%), while nearly half (44Æ3%) experienced
unfavourable changes in their bite. Favourable change
was described as patients with Class II and significant
overjet which improved; unfavourable change was
observed in Class I patients who developed edge to
edge overjet or reverse overjet.
Surgical orthodontic treatment options
While dental appliances work well in patients with mild
to moderate obstructive sleep apnoea, they are not
universally effective and may not be appropriate in
more severe cases. For patients with severe sleep
apnoea, who do not desire or cannot tolerate long-
term CPAP therapy, oral and maxillofacial surgery in
conjunction with orthodontic decompensation is a
proven treatment alternative. Historically, a tiered
surgical approach has been utilised. Given the nature
of surgical therapy, well-controlled clinical studies are
difficult to perform. Control subjects are difficult to
obtain, subjects may be randomly assigned, but they
know whether they have had surgery, and for ethical
purposes, ‘sham’ surgical procedures are inappropriate.
Finally, once surgical success is demonstrated, it is no
longer ethical to withhold treatment so a patient can
serve as a control. As a result, the level of evidence
available for making treatment decisions is lower. There
are retrospective case series, prospective case series,
limited prospective randomised (with randomization of
two different types of surgery) studies available. To
date, there are no prospective randomised controlled
studies available.
Genioplasty. The advancement genioplasty represents a
first tier surgical therapy for obstructive sleep apnoea
(56). The best candidates have a functional Class I
occlusion, good maxillary and mandibular skeletal
positioning, but deficient bony chin projection called
retrogenia. When severely deficient, it is defined as
microgenia. Retrogenia refers only to the size and
position of the bony chin; it does not describe the size,
shape, or position of the mandible itself. A retrogenic
patient may have a normal mandible, a large mandible,
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or a small mandible. When the patient has a small
mandible and a small chin button, they can be
described as retrognathic and retrogenic. Several forms
of genioplasty may be performed. Each must assure that
the genial tubercles are in the segment that is surgically
advanced.
Evidence for genioplasty. The evidence for isolated gen-
ioplasty to improve OSA is extremely limited, largely
anecdotal, and comes from case reports and limited case
series (57). In a 1984 case report, a patient with OSA
underwent an inferior border osteotomy to advance the
genial segment (though there is no notation of how far),
and the patient’s OSA improved ‘significantly’. Follow-
ing this study, the authors initiated an investigation
utilising genioplasty and hyoid suspension. Of the 239
patients enrolled, only 145 (60%) were successfully
treated. While other patients improved, their improve-
ment was insufficient to bring them into the normal
range and they were left with inadequate resolution of
the OSA. Another drawback is that other investigators
have attempted to replicate this centre’s results and the
isolate genioplasty has fallen out of favour.
Mandibular advancement. Because of the limited success
resulting from isolated genioplasty, Bear (58) reported
on surgical mandibular advancement. With this type of
surgical intervention, the entire body of the mandible is
brought forward. When utilised in conjunction with a
genioplasty, significantly larger advancements (mea-
sured at pogonion) are obtained. Though additional
advancement is possible, this approach has limited
success and multiple complicating factors. Without
presurgical orthodontics, the width of the maxilla is
typically too narrow to accommodate the advanced
mandible. This forces the surgeon into one of three
problematic scenarios. First, the surgeon may continue
to advance the mandible into good a sagittal position
but a posterior cross bite resulting in undesirable lateral
shifts and adverse temporomandibular joint health.
Alternatively, the surgeon can advance the patient into
both an anterior and a posterior cross bite; i.e. create a
significant post-operative malocclusion with dimin-
ished orofacial function but good airway. The final
problem is the surgeon may not be able to advance the
mandible enough to resolve the OSA.
Evidence for mandibular advancement. Other than the
initial case report, little evidence is present for isolated
mandibular advancement. In 1990, an investigation
was performed on the posterior airspace changes
resulting from mandibular advancement surgery (59).
In the study, the posterior airway space was measured
in 25 adult patients before and after surgical mandib-
ular advancement. The airway change ‘generally
increased but was variable’ indicating that some
patients experience greater change than others. None
of these patients were diagnosed with OSA, but because
of the two-dimensional airway change measured on the
radiograph, the authors imply that mandibular
advancement may have benefit to patients with OSA.
Maxillomandibular advancement (MMA). Following the
failure of other surgical options, MMA, to advance
both the maxilla and the mandible was initiated.
According to some, this has now become the gold
standard in surgical orthodontic care for OSA (60).
Multiple case reports and controlled case series avail-
able in the literature discuss the benefits of maxillo-
mandibular advancement to increase airway patency
(6, 61–63).
MMA gives the surgeon the ability to maintain a
functional occlusion in Class I patients or enhance the
functional occlusion in Class II and Class III patients
while simultaneously improving the airway and the
profile. Most patients with OSA wish to pursue MMA
very quickly to resolve their condition and do not desire
the necessary presurgical orthodontic treatment. As a
result, one of the risks associated with MMA is post-
operative malocclusion. To avoid such complications,
the preferred treatment approach addresses the under-
lying malocclusion first with presurgical orthodontic
therapy to obtain complementary maxillary and man-
dibular dental arches. The orthodontic treatment plan
determines where the teeth will be positioned in the
respective jaws and the surgical plan determines where
each jaw will be positioned relative to the cranial base.
For Class I skeletal and dental patients, similar
amounts (typically 10 mm) of maxillary and mandib-
ular surgical advancement are performed. Patients with
a Class II malocclusion undergo larger surgical man-
dibular advancement in order to achieve a Class I dental
and skeletal relationship. Because the mandible is
advanced further, a wider portion of the mandible will
articulate with a narrower portion of the maxilla
following surgery. To widen the maxilla, either an
initial surgical stage of surgical assist rapid maxillary
expansion (SARME) or a segmental LeFort I osteotomy
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can be performed at the same time as the definitive
maxillomandibular advancement surgery (64, 65).
When smaller amounts of maxillary widening
(5-6 mm) are needed, segmental LeFort I osteotomy
can be sufficient. (See Fig. 6) Where larger amounts of
expansion are needed (6+ mm) SARME is preferred.
(See Fig. 7) Class III patients require larger amounts of
maxillary surgical advancement to achieve a Class I
occlusion. While Class III patients may present with the
maxillary arch completely encompassed by the man-
dibular arch (bilateral posterior cross bite with an
anterior cross bite) following the surgical maxillary
advancement, the maxilla may be too wide because a
wider portion of the maxilla now articulates with a
narrower portion of the mandible. These and several
other considerations regarding the surgical orthodontic
treatment planning necessary to achieve ideal results
are covered more extensively in other publications
(66).
CPAP or alternative forms of OSA treatment are used
during the presurgical orthodontic phase to reduce the
negative effects of OSA. Progress models are taken
frequently to assess the presurgical orthodontic prepa-
ration. Once complementary arches are obtained, MMA
is performed enabling both an improved airway and an
improved occlusion to be obtained concurrently. After
adequate post-operative healing, a follow-up polysom-
nography is performed to assure resolution of the OSA.
For most patients, the AHI will be back in the normal to
mild range (AHI < 10) and CPAP can be discontinued.
An unexpected yet beneficial side effect of MMA
surgery is most orthognathic surgery patients experi-
ence mild weight loss (typically 10 pounds or more)
during the immediate post-operative period, which can
also contribute to reducing the AHI.
Evidence for MMA. The evidence for MMA comes from
case reports, retrospective controlled case series and
prospective case series. While overall the evidence
reported to date is positive for MMA more work
remains. Future well-controlled investigations must be
performed to enhance the strength of the evidence for
MMA surgery. Surgical centres may have prospective
clinical protocols in place for such study but these have
not yet been made known.
In one of the earliest MMA case reports, Vila et al.
(67) describes a patient with severe mandibular defi-
ciency and an AHI of approximately 58. Prior to
undergoing the MMA, the patient received a tracheos-
tomy to bypass the airway and resolve the OSA.
Following the MMA, the authors report that the patient
improved dramatically. A post-operative lateral cepha-
logram revealed a significantly larger sagittal airway
dimension. At post-operative day 15, the tracheostomy
tube was removed. Similar case reports are available in
Fig. 6. A schematic drawing of a segmented LeFort I osteotomy.
The osteotomy is performed between the maxillary lateral incisors
and the maxillary canines in order to obtain both canine and
molar expansion. Care must be taken to prevent kinking the
gingival pedicle to preserve both tissue and tooth health.
(a) (b)
Fig. 7. (a) The intra-operative view of the surgical assist rapid palatal expansion. A circumferential cut is made above the level of the
maxillary tooth roots. Finally, the osteotome is placed in the mid-sagittal region to split the suture. (b) demonstrates the significant
amount of expansion that can be obtained following activation of the appliance.
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the literature indicating the growing popularity of
MMA surgical therapy.
One of the earliest retrospective consecutive case
series publications examined patients with an AHI > 20,
cephalometric evidence of maxillary and ⁄ or mandibu-
lar retrusion and a diminished posterior airway space
were included (61). Each patient was intended to
undergo 10 mm MMA ‘to secure success,’ though no
reference is given and it is unclear how 10 mm was
selected. In fact, even now, no clear evidence exists that
a 10 mm MMA will assure success. Post-operatively, all
patients improved; (AHI of 44Æ9–3Æ6). Nearly all (20 of
the 21) patients improved to an AHI of <10. From these
results, the authors postulated that patients should be
treated with a definitive MMA rather than a geniopl-
asty or mandibular advancement.
A subsequent case series reports on surgical patients
recruited from a large initial pool of 540 patients. A
small subset (210) met the cephalometric criteria for
MMA; the majority (193) opted for nCPAP, while the
rest (15) opted for MMA. In the surgical patients, mean
AHI improved (51Æ4 initially, 5Æ0 six weeks post-oper-
atively and 8Æ5 at 2 years post-operatively). Conserva-
tive nCPAP patients were treated more effectively (AHI
3Æ9) at the 2 -year time point. Several other studies
were published showing high but variable levels of
success (68–70).
In a prospective study of 53 patients published in
2000, a tiered surgical approach was used (69). Of the
53 patients originally enrolled, 44 underwent Phase 1
genioplasty surgery which was further subdivided into
two different genioplasty designs that were largely
ineffective at resolving the OSA (IA: 24% success IB:
22% success). Phase II surgery (MMA) was successful
in 75% of patients (15 of 20). This study illustrates
many of the challenges encountered when performing
prospective studies. Comparison is made difficult
because of the multiple treatment protocols employed.
In addition, only 13 of the original 53 patients (25%)
went through the entire protocol, which makes draw-
ing meaningful conclusions difficult. Lastly, the criteria
used for success were moderate at best requiring either
a greater than a 50% decrease in AHI or a post-
treatment AHI < 15 which still places patients in the
mild OSA category.
Sagittal maxillary and mandibular distraction osteogene-
sis. Distraction osteogenesis can be performed in the
sagittal dimension to achieve even larger advancements
than traditional MMA. One of the advantages of
distraction is the patient can undergo a polysomnogra-
phy during the course of distraction. Distraction can be
continued if resolution of the OSA has not occurred or
discontinued as soon as success has been achieved.
Currently, limited evidence has been published dis-
cussing the potential benefits of sagittal distraction
osteogenesis. The first report discusses a patient who
underwent mandibular distraction osteogenesis first
followed by a second stage LeFort I maxillary advance-
ment (71). Polysomnography was conducted after
6 mm of distraction with the results indicating addi-
tional advancement was needed. The process was
repeated at 12 mm of mandibular distraction and the
AHI was reduced to 23. Because the minimum oxygen
saturation was brought into the normal range, distrac-
tion was stopped. Two months later, the maxilla was
advanced to ‘a harmonious position’. It is unclear why
distraction was utilised in this patient as previous
reports have demonstrated successful one stage surgical
advancement of 12+mm. A subsequent case report
discusses bimaxillary distraction osteogenesis; osteoto-
mies were performed in the maxilla and mandible
concurrently and a tracheostomy was performed to
assure airway patency. The two jaws were wired
together, suspension wires were placed, and distractors
were positioned on the mandible bilaterally. At 18 mm
of distraction, incomplete resolution of the OSA was
observed during polysomnography. Distraction contin-
ued for a total of 22 mm of advancement. Follow-up
sleep study indicated complete resolution with an AHI
of 2Æ7.
Finally, one limited case series reporting on bimax-
illary distraction osteogenesis is presently available.
Direct comparison is difficult as different procedures
were performed on the five patients. One patient
underwent unilateral mandibular distraction, four
patients underwent bilateral mandibular distraction,
and one patient underwent combined maxillomandib-
ular distraction. All patients improved with the mini-
mum oxygen saturation climbing from 79% to 85%
and the RDI decreasing from 49Æ3 to 6Æ6 events per
hour. It is important to note, the distraction ranged
from 5Æ5 mm to a maximum of 12Æ5 mm, which is
within the range of standard maxillomandibular
advancement. With the inherent difficulties involved
in distraction osteogenesis over standard LeFort I and
BSSO advancements, the advantage of the newer
technique is unclear. Should patients require larger
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movements, distraction may offer enhanced results.
The authors correctly conclude that additional study is
required.
Maxillary and mandibular transverse distraction osteogene-
sis. Reports conflict regarding the size, shape, and form
of the dental arches and facies of the average adult
obstructive sleep apnoea patient. Anecdotal evidence
from case series reported in the literature appears to
illustrate a component of transverse deficiency in both
jaws. The magnitude of the transverse deficiency varies
from patient to patient, with some patients exhibiting
extreme narrowness to both jaws. With the reports
from the paediatric and adolescent sleep literature
demonstrating improvement in OSA resulting from
palatal expansion, (see Part II), one must theorise that
expansion of the adult dental arches could produce
similar improvement. Unfortunately, stable non-surgi-
cal skeletal expansion of the maxilla in an adult is not
possible. To obtain the necessary expansion, maxillary
transverse distraction osteogenesis (previously called
surgical assisted rapid maxillary expansion or SARME)
is required. Historically, the amount of maxillary
expansion that can be achieved has been limited by
the mandibular arch because the mandible could not be
stably expanded. With the advent of mandibular
symphyseal distraction osteogenesis, now expansion
of both arches can be considered (72–74). A useful
clinical guideline is that the mandible cannot be
expanded more than about 10 mm. As a result, if the
patient presents with a narrow maxilla and narrow
mandible but no cross bite, no more than 10 mm of
expansion in both arches should be planned. If how-
ever the maxilla and mandible are narrow, and a cross
bite exists, then, the mandible can be expanded 10 mm
and the maxilla a greater amount. This must be assessed
and examined using diagnostic models, an occluso-
gram, and a PA cephalograph. The PA cephalograph
and a set of adolescent and adult normative values can
help determine the appropriate size of the maxilla and
mandible (75).
Evidence for maxillary and mandibular transverse distraction
osteogenesis. A recent case report illustrates the success-
ful incorporation of bimaxillary transverse distraction
osteogenesis in combination with maxillomandibular
advancement in an adult male with severe obstructive
sleep apnoea (76). The pre-treatment RDI of 60 was
reduced to a post-treatment RDI of 4. Unfortunately, no
interim sleep study was performed leaving the reader
to speculate how much correction resulted from the
transverse distraction osteogenesis and how much
resulted from the maxillomandibular advancement.
Some recent work involving CBCT, acoustic rhinom-
etry, and posterior–anterior cephalometry has evalu-
ated the airway dimension following surgical assist
rapid palatal expansion (77–79). These reports present
conflicting information. The posterior–anterior as well
as lateral cephalometry report by Malkoc (78) indicates
minimal to no effect on pharyngeal airway dimensions
or hyoid positioning in the twenty patients examined.
The CBCT evaluation of 38 patients demonstrated
increased palatal area, palatal volume, inter-molar
distance, and decreased nasal resistance (77). The
decrease in nasal resistance was maintained over the
remainder of the study period. Unfortunately, the effect
of decreased nasal resistance in OSA can only be
postulated as none of the study patients underwent
polysomnography before or after treatment.
Conclusions
Oral appliance therapy has been investigated the most
thoroughly and demonstrates one successful form of
treatment that the dentist and dental specialist can
provide. Surgical options that combine the care of an
orthodontist and an oral and maxillofacial surgeon
appear to be more successful, but the evidence levels
are still low (case reports, retrospective case series, and
controlled prospective case series). While the evidence
appears to be good, additional stringent study is
required to continue to strengthen the professions role
in treating adult patients with OSA.
Part 2: the paediatric and adolescent
patient
Diagnosis and classification of paediatric
obstructive sleep apnoea
Patients with paediatric sleep apnoea often have more
complex medical histories. Because sleep apnoea
manifests differently in children, the dental profes-
sional should follow up on attention deficit disorder
attention deficit and hyperactivity disorder (AD-
D ⁄ ADHD), cor pulmonale, failure to thrive, and
mouth breathing (3). The medical history evaluation
should also ask questions regarding snoring, nocturnal
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gasping, and bed wetting as each are associated with
OSA in children.
In the paediatric patient, dental professionals must
examine the oropharynx because the primary cause of
OSA is tonsilar and adenoid hypertrophy (80). Both the
lingual and pharyngeal tonsils will be visible intra-
orally but the adenoids will not. Tonsilar size ranges
from Type 0 where the tonsils are absent to Type IV
where the right and left tonsilar tissues approximate
each other in the midline. In the lateral cephalometric
radiograph, the tonsils are observed as a moderately
radiopaque mass in the region of the mandibular gonial
angle while the hypertrophic adenoids appear above
the soft palate. (Fig. 8). While lymphatic tissue nor-
mally shrinks in volume after the age of six (81) the
hypertrophic tonsilar and adenoid tissue may be so
large that normal tissue reduction is insufficient to
remove the obstruction (Fig. 9). When hypertrophic
tonsils are observed clinically or radiographically,
referral for endoscopic evaluation and possible surgical
removal by a paediatric otolaryngologist should be
made. Early removal can reduce the tendency for
patients to manifest the anecdotal potential adverse
long face growth pattern with narrow upper and lower
dental arches and anterior open bite (82).
Other potential causes of OSA in the paediatric
population are maxillary transverse deficiency and
obesity (83, 84). Estimates of overweight and obesity
prevalence ranging from one in four to one in three
children have been published. This early weight
Fig. 8. Lateral cephalometric tracing that includes the adenoids
(dashed line) and palatine tonsils (dotted line).
(a)
(b)
Fig. 9. (a) Scammon’s curves demonstrate the different rates of
growth of the different tissues in the body. Note the excessive
lymphoid tissue overgrowth that shrinks as continued develop-
ment occurs. It is important to note that the maxilla grows more
along the neural growth curve and the mandible follows the
general growth curve. Scammons curves. (b) Intra-oral view of a
patient with excessive palatine tonsilar tissue. Reprinted from
Proffit WR. Later stages of development. In: Proffit WR, Fields HW
Jr. and Sarver DM, eds. Contemporary Orthodontics, 4th ed. St.
Louis (MO): Elsevier; 2007:108.
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problem presents at least a two fold problem. First,
children are developing OSA much earlier, leading to a
lifetime treatment need. Second, the increased child-
hood weight increases the risk of being overweight or
obese as adults.
Craniofacial anomalies can also contribute to paedi-
atric sleep apnoea. These include both severe mandib-
ular deficiency disorders (such as Pierre Robin
sequence, Goldenhaar Syndrome), severe maxillary
deficiency (Crouzon, Aperts, cleft lip  palate) and
vertical facial anomalies (Marfans and associated 22q
deletion syndromes) (24, 85).
Paediatric OSA treatment modalities
Because paediatric OSA has not been recognised as long
as adult OSA, fewer treatment modalities exist. For the
treatments that are available, fewer levels of evidence
are present. A brief examination of the common
treatment methods available to the dentist and dental
specialist along with the evidence base follow.
CPAP and its potential craniofacial complications
For the severely affected adolescent patient, CPAP has
been advocated. Within the adult population, cranio-
facial side effects of CPAP have either not been
observed or not been reported. Within the paediatric
and adolescent population, anecdotal reports of poten-
tial growth disturbances from long-term use of CPAP
have been reported. Figure 10 shows a patient with
sleep apnoea who has been undergoing treatment with
CPAP for several years. Unfortunately, she was not
observed clinically or radiographically by an orthodon-
tist prior to the CPAP being administered, so it is
unclear how much of the malocclusion results from
CPAP and how much results from an underlying
adverse growth pattern. From a biomechanical stand-
point, there is potential validity; the elastic strap that
maintains the mask does apply a restraining force on
the maxilla not unlike the effect an orthodontic
headgear. To adequately answer this question, prospec-
tive randomised clinical evaluation needs to be per-
formed. If growth is negatively affected from CPAP,
individualised assessment and treatment planning will
need to be carried out in order to treat the more serious
condition (i.e. the OSA or the malocclusion) and leave
definitive treatment of the less serious condition for
later.
Rapid maxillary expansion (RME)
When examining the paediatric or adolescent dentition,
attention should be directed first towards the transverse
dimension. Many patients with OSA, particularly pae-
diatric patients demonstrate a maxillary transverse
deficiency (cross bite) where the upper teeth are too
narrow to occlude properly with the mandibular teeth
(86, 87). This can present as a single tooth cross bite, a
unilateral cross bite where the right or left side is too
narrow, or a bilateral cross bite where both sides are too
narrow. With the unilateral cross bite, one must
determine whether this is a true unilateral cross bite
(no shift) or whether the patient has a bilateral cross
bite with a lateral shift. In paediatric patients, what
appears to be a unilateral cross bite typically is a
bilateral cross bite with a shift. To distinguish the two,
(a)
(b)
Fig. 10. (a) This lateral cephalometric image of a 12-year
3-month-old female with OSA who has received treatment with
CPAP for over 3 years. Note the severe maxillary retrusion. (b)
Lateral intraoral view.
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one must observe the patient opening and closing. In a
bilateral cross bite with a shift, the patient starts in
complete cross bite on one side with the lower dental
midline deviated to that side. During opening, the
lower dental midline will shift back into alignment with
the maxillary midline. During closing, one often
observes the patient hit prematurely on one side that
deflects the jaw. The true unilateral cross bite is rare
and when present, the patient bites in cross bite with
the midlines off and opens without any noticeable shift.
At the fully open position, the midlines will be off the
same amount as when biting down.
The presence of a cross bite can be positively or
negatively affected by the sagittal bite relationship. In
Class II patients (maxillary molar and canine positioned
more forward than the mandibular molar and canine),
the patient may appear to have appropriate transverse
dimension. However when the mandible is positioned
more anteriorly to simulate growth or surgical correc-
tion, a cross bite can be observed. Conversely, with a
Class III malocclusion, the maxilla may appear too
narrow, but when the maxilla is brought forward, (or
the mandible brought back), the transverse relationship
may be adequate. All patients must be examined both
in their initial bite position and in the anticipated final
sagittal bite position.
Evidence for RME
Recently, several publications provide direct evidence
of the positive effects of rapid maxillary expansion in
children diagnosed with obstructive sleep apnoea (83,
86, 88–91) (See Fig. 11). Palmisano published the first
piece of with Cistulli following up this work with two
additional publications (86, 88, 89) Palmisano reported
on 10 ‘young’ patients (range 14–37 years old); nine of
the patients improved with seven brought into the
normal range. One patient had no improvement.
Obvious weaknesses of the study include small sample
size (n = 10), a variety of expansion techniques (six
surgical expansion, four non-surgical), patients only
had mild to moderate sleep apnoea, and the study
combines adolescent and adult patients. The mean
canine, premolar, and molar expansion was 5Æ6, 7Æ8,
and 8Æ1 mm, respectively. AHI improved from 19Æ4 to 7
post-expansion. Pirelli (83) addressed several of these
limitations by investigating expansion in 31 children.
The mean age was 8Æ68 with a mean pre-treatment AHI
of 12Æ2. The experimental group was stratified into
three categories; AHI of 5–10, 10–15 and 15+ with the
largest group in the 10–15 range. Immediately follow-
ing expansion (mean expansion was 4Æ32 mm) 29 of
the 31 patients had an AHI < 5. At follow-up
(6–12 months post-expansion), all patients were
brought into the normal range (AHI < 1). The final
improvement may have resulted from appliance removal
following expansion allowing the tongue greater room.
Villa (90) performed a prospective examination of 16
patients (mean age 6Æ9; range 4Æ5–10Æ5) 1 year following
the RPE. This study not only examined the effect of
expansion but also noted the size of the tonsils. While
two patients were lost to follow-up, AHI improved from a
mean of 5Æ8  6Æ8 at the start to a mean of 2Æ7  3Æ5
at 6 -month follow-up and ended at 1Æ5  1Æ6 at
12 -month follow-up even with the presence of enlarged
tonsils in 11 of the 14 patients demonstrating that
expansion alone can produce significant improvement in
(a)
(b)
Fig. 11. (a) Rapid maxillary expansion appliance. (b) The same
appliance after cementation to the maxillary first molars and first
premolars bilaterally.
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OSA. For the small subset of patients who were
not sufficiently corrected, the residual OSA may have
been better treated by tonsillectomy following
expansion.
In a higher level of evidence, Miano (91) performed
the first study to utilise a control group to examine the
effect RPE has on the REM and non-REM portion of
sleep. One limitation of the study is the small sample
(only nine patients available because of ‘significant
artefacts’ present in the polysomnography exams) and
the presence of large tonsils. In the RPE group, AHI
improved (17Æ4–5Æ4) total sleep time improved (393–
410 min), but sleep architecture was still altered. Even
though the AHI improved the percentage of REM sleep
by the OSA patients declined slightly (20Æ3% to 17%).
In addition, even though the total sleep time improved,
following expansion, the patients with OSA still slept
less than age matched controls (410 min versus
526 min). The likely cause of the lack of ‘normalisation’
is the incomplete resolution of the OSA (mean AHI
post-RPE was 5Æ4 indicating the presence of significant
OSA). The patients whose OSA was not resolved may
have benefited from a post-expansion tonsillectomy as
well.
The precise mechanism(s) for decreasing obstructive
events via rapid maxillary expansion are not fully
understood at this time. The improvement may stem
from treating multiple causes and multiple sites. As
reported in the cephalometric and acoustic rhinometry
studies, as the maxilla expands, the palate and floor of
the nasal cavity also expand which increases the
volume and decreases airflow resistance within the
nasal cavity. This expansion also causes statistically
significant though clinically small changes in tongue
size, tongue position, hyoid position, resulting from the
direct expansion of the maxillary dentition (78). This
larger upper arch may allow the tongue greater space
and allow for more forward positioning of the tongue.
Finally, the effect of widening the maxillary basal bone
on the velum, the superior pharyngeal constrictors, and
the surrounding orofacial musculature can not be
under emphasised. Increased muscle tone is impossible
to assess radiographically or clinically but could be
performed with electromyography (EMG). To date,
these studies have not been conducted. Although each
component (increased nasal floor, increased upper arch
size, and increased muscle tone) may contribute only a
small amount to the correction, the combination
appears to be clinically significant and tremendously
beneficial to the patient, in the publications reported to
date.
Several publications give ‘indirect evidence’ of the
benefit of RPE in the treatment of OSA (77, 78, 92–96).
The second group of studies providing indirect evidence
utilises various imaging modalities to provide anatom-
ical evidence for increased airway dimensions (77, 78,
93, 96). Additional publications describe the similar
effects resulting from surgical assist rapid palatal expan-
sion performed in patients who are more skeletally
mature (79, 97, 98). In these studies, lateral cephalo-
metric evaluations, frontal (posterior-anterior) cepha-
lometric evaluation, cone beam computed tomography,
or conventional computed tomography are used to
make linear and angular measures of the nasal cavity,
pharyngeal airway, and the associated structures. The
final pair of studies that indirectly suggest RPE may be
beneficial in the treatment of OSA utilise acoustic
rhinometry to evaluate the functional and volumetric
airway changes (94, 95). Two major flaws with all of
these ‘indirect levels of evidence studies’ are none of
them were performed on patients with OSA and none
of the utilised polysomnography.
Paediatric sagittal growth modification
Evidence for Class II growth modification therapy. It has
been well documented in the adult patient with OSA
that mandibular anterior repositioning appliances can
be quite effective. This success leads one to presume
that similar treatment could be effective in the adoles-
cent patient as well. Given the large number of
appliances commonly used to advance the mandible
for orthodontic purposes (Herbst, Mara, Twin Block,
Bionator, Frankel 2, etc), several treatment modalities
currently employed by orthodontists could be used for
children with obstructive sleep apnoea.
To date, only one study assessing sagittal growth
modification in the paediatric OSA population (99). The
study strengths are its randomised patient allocation
and the use of an untreated control group. Unfortu-
nately, the study has some significant weaknesses
including a small sample size (19 treated and 13
controls), large number of patients lost to follow-up,
(five treated and four controls) and a low threshold for
success. Fortunately, the treated and control group
were remarkably similar in height and weight. Some
group differences were present (two experimental
patients had cross bite). Interestingly, the nine patients
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lost to follow-up were the heavier, taller and older
patients.
Unlike adult patients, the treated adolescent patients
wore the mandibular advancement appliance full time
(except when eating) in an attempt to treat both the
obstructive sleep apnoea and the deficient mandibular
growth. All patients improved and the mean AHI
dropped from a pretreatment of 7Æ1 to a post-treatment
of 2Æ6. Using the low threshold for success of a 50%
decrease in AHI, the majority of patients (64%) were
successfully treated. Using the more stringent level of
success of normalising the AHI, only 50% of patients
were successfully treated. While these early results are
encouraging, follow-up studies that enrol greater num-
bers of patients, treat for a longer period of time, and
impose more stringent threshold for success must be
performed. Lastly, it was not reported whether follow-
ing the study period these patients would continue to
be tracked. If they are not it is unclear whether the
improvement gained from treatment will be sustained.
In addition, one must remember that treatment with
mandibular anterior repositioning appliances in non-
OSA patients is not 100% successful. In patients where
growth modification is successful, at best, the maxi-
mum skeletal component of mandibular advancement
appliances is approximately 66–75% of the total
movement (100). In patients who ‘relapse’ both the
malocclusion and the OSA may return.
One other study offering indirect evidence in Class II
mandibular deficient patients presented radiographic
evidence of increased airway from a Harvold activator
(101). A link between the airway and OSA was
presented, but none of the patients treated were known
to have OSA as no polysomnography was performed.
The authors conclude that because the airway dimen-
sions increased in certain Class II patients, further study
is indicated.
Evidence for Class III growth modification therapy. As
mentioned earlier, both maxillary and mandibular
skeletal deficiency can contribute to OSA in adults
and children. One treatment strategy for the young
Class III maxillary deficient orthodontic patient is
protraction face mask (also known as reverse pull
headgear) (102). With this form of treatment, the
maxilla is typically widened first with RPE followed
immediately by orthopaedic traction to bring the
maxilla forward. For small maxillary deficiencies, this
form of orthopaedic treatment can be quite successful.
For more severe maxillary deficiencies (ANB > )6),
protraction is less successful.
Improvement of paediatric OSA from the RPE com-
ponent of the Class III growth modification therapy has
previously been demonstrated. Correction resulting
from the protraction head gear is less clear and only
indirect evidence is available. Five recent publications
report that pharyngeal airway dimensions increase
following orthopaedic protraction of the maxilla though
each has significant limitations; most notably, poly-
somnography was not performed in any of the five
papers (103–107). Additionally, one paper reports
radiographic improvement in airway, though this was
not demonstrated in the raw data (103). The improved
airway was only observed after multiple regression
analysis was performed to ‘remove confounding vari-
ables’ which may not have been appropriate. Finally,
many papers evaluating Class III treatment are per-
formed on patients who are relatively young and may
outgrow the treatment. Kaygisiz (107) attempts to
address this by performing a 4 -year follow-up after
maxillary protraction growth therapy. In this treatment
group, both the positive skeletal and airway changes
remained stable over the 4 -year evaluation period.
However, one must remember from previous Class III
growth modifications that not all patients will experi-
ence the positive maxillary growth. If growth is not
enhanced, airway changes are not likely to be obtained.
Unfortunately, until Class III growth modification
studies are performed utilising polysomnography the
evidence for growth modification in Class III treatment
will remain indirect and weak. Its potential, however,
should not be discounted especially with the encour-
aging reports of enhanced protraction with skeletal
anchorage that are being reported (108, 109).
Conclusions
OSA has gone from being a largely unknown condition
to being a condition that affects multiple medical and
dental disciplines. Dental professionals must screen for
OSA in both their paediatric and adult new patient
examinations. When signs or symptoms of OSA are
observed, the dental professional must implement
appropriate referrals for definitive diagnosis. Early
recognition of mouth breathing and airway obstruction
by the paediatric dentist, general dentist, or orthodon-
tist can facilitate early treatment and correction of OSA
in the paediatric population. Once OSA is diagnosed,
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treatment protocols that have been consistently utilised
for orthodontic malocclusion, (RPE, Class II and Class
III growth modification), may now be used to resolve
OSA. When faced with the adult patient who has signs
and symptoms of obstructive sleep apnoea, dental
professionals must consult more diligently with their
medical colleagues. Sleep studies must be considered
when making treatment decisions. Sound dental and
medical treatment decisions as outlined earlier can be
the ‘ounce of prevention that is worth a pound of cure’.
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